EMFAT
Emerald Mutual Fund Advisers Trust’s Madrigal Pharmaceuticals MDGL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $11.2M | Buy |
36,920
+1,682
| +5% | +$509K | 0.68% | 54 |
|
|
2025
Q1 | $11.7M | Buy |
35,238
+16,582
| +89% | +$5.49M | 0.83% | 46 |
|
|
2024
Q4 | $5.76M | Sell |
18,656
-3,031
| -14% | -$935K | 0.35% | 86 |
|
|
2024
Q3 | $4.6M | Sell |
21,687
-54,072
| -71% | -$11.5M | 0.24% | 106 |
|
|
2024
Q2 | $21.2M | Hold |
75,759
| – | – | 1.11% | 35 |
|
|
2024
Q1 | $20.2M | Buy |
75,759
+36,479
| +93% | +$9.74M | 1.05% | 34 |
|
|
2023
Q4 | $9.09M | Buy |
+39,280
| New | +$9.09M | 0.48% | 83 |
|
|
2023
Q3 | – | Sell |
-50,073
| Closed | -$11.6M | – | 246 |
|
|
2023
Q2 | $11.6M | Sell |
50,073
-16,125
| -24% | -$3.72M | 0.63% | 75 |
|
|
2023
Q1 | $16M | Buy |
66,198
+55,729
| +532% | +$13.5M | 0.95% | 40 |
|
|
2022
Q4 | $3.04M | Buy |
+10,469
| New | +$3.04M | 0.19% | 115 |
|